← Every applicant
Glenmark Speclt FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| FLUTICASONE PROPIONATENew drugAug 18, 2026SPRAY, METERED, NASAL |
| FLUTICASONE PROPIONATENew drugMar 16, 2026SPRAY, METERED, NASAL |
| FLUTICASONE PROPIONATENew drugMar 3, 2026AEROSOL, METERED, INHALATION |
| ESOMEPRAZOLE MAGNESIUMNew drugJun 11, 2024CAPSULE, DELAYED RELEASE, ORAL |
| RYALTRISNew drugJan 13, 2022SPRAY, METERED, NASAL |